The threat of contamination of biological products, namely vaccines, biotherapeutics and biologics is a major source of concern for laboratories, pharmaceutical companies and other research & educational establishments. Such contaminations may arise as a result of chemical impurities, fungi, bacteria and viruses. The occurrence of viral contamination affects the raw materials, cell culture, bioreactors and several downstream processes. Therefore, practicing virus safety and virus filtration studies is extremely pivotal in the process of manufacturing as well as research studies.
Market Industry Reports (MIR) has published a new report titled “Virus Filtration Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global virus filtration market is estimated to be over US$ 1,200 Mn in 2017. It is anticipated to grow at a CAGR of 12.1% from 2019 to 2030. The continual increasing adoption of biopharmaceuticals, namely biologics and other biotherapeutics has presented a bright prospect for the growth of virus filtration market. Increasing funding for R&D has further led to wide scale adoption of these filtration products for clearance of virus.
Major Key Players of the Virus Filtration Market are:
Asahi Kasei, Merck KGaA, Sartorius AG, Thermo Fisher Scientific, General Electric, Charles River, PendoTECH, Danaher, Lonza and Medical Respiratory Devices among others
Asahi Kasei, Merck KGaA, Sartorius AG, Thermo Fisher Scientific, General Electric, Charles River, PendoTECH, Danaher, Lonza and Medical Respiratory Devices among others
No comments:
Post a Comment